The effect of eculizaumab combined with double filtration plasmapheresis in improving recovery outcomes in ABOi-KT patients
{{output}}
Background: ABO-incompatible kidney transplants are acceptable, but special considerations are critical. This study evaluated the efficacy of eculizumab, an antibody that blocks the cleavage of the complement C5 component into C5... ...
